| Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart B Zhou, Q Ma, S Rajagopal, SM Wu, I Domian, J Rivera-Feliciano, ... Nature 454 (7200), 109-113, 2008 | 1152 | 2008 |
| Altered microRNA expression in human heart disease S Ikeda, SW Kong, J Lu, E Bisping, H Zhang, PD Allen, TR Golub, ... Physiological genomics 31 (3), 367-373, 2007 | 812 | 2007 |
| MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes S Ikeda, A He, SW Kong, J Lu, R Bejar, N Bodyak, KH Lee, Q Ma, ... Molecular and cellular biology, 2009 | 512 | 2009 |
| The biology of Hepatocellular carcinoma: implications for genomic and immune therapies G Khemlina, S Ikeda, R Kurzrock Molecular cancer 16, 1-10, 2017 | 382 | 2017 |
| Landscape of phosphatidylinositol-3-kinase pathway alterations across 19 784 diverse solid tumors SZ Millis, S Ikeda, S Reddy, Z Gatalica, R Kurzrock JAMA oncology 2 (12), 1565-1573, 2016 | 259 | 2016 |
| Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure E Bisping, S Ikeda, SW Kong, O Tarnavski, N Bodyak, JR McMullen, ... Proceedings of the National Academy of Sciences 103 (39), 14471-14476, 2006 | 231 | 2006 |
| Heart failure–associated changes in RNA splicing of sarcomere genes SW Kong, YW Hu, JWK Ho, S Ikeda, S Polster, R John, JL Hall, E Bisping, ... Circulation: Cardiovascular Genetics 3 (2), 138-146, 2010 | 160 | 2010 |
| Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy S Ikeda, AM Goodman, PR Cohen, TJ Jensen, CK Ellison, G Frampton, ... NPJ genomic medicine 1 (1), 1-5, 2016 | 143 | 2016 |
| Genomic alterations in circulating tumor DNA from diverse cancer patients identified by next-generation sequencing M Schwaederle, R Chattopadhyay, S Kato, PT Fanta, KC Banks, IS Choi, ... Cancer research 77 (19), 5419-5427, 2017 | 114 | 2017 |
| Expression and function of microRNAs in heart disease S Ikeda, W T Pu Current drug targets 11 (8), 913-925, 2010 | 82 | 2010 |
| Next‐generation sequencing of circulating tumor DNA reveals frequent alterations in advanced hepatocellular carcinoma S Ikeda, IF Tsigelny, ÅA Skjevik, Y Kono, M Mendler, A Kuo, JK Sicklick, ... The oncologist 23 (5), 586-593, 2018 | 80 | 2018 |
| Molecular landscape of prostate cancer: implications for current clinical trials G Khemlina, S Ikeda, R Kurzrock Cancer treatment reviews 41 (9), 761-766, 2015 | 77 | 2015 |
| Notch3 in human breast cancer cell lines regulates osteoblast-cancer cell interactions and osteolytic bone metastasis Z Zhang, H Wang, S Ikeda, F Fahey, D Bielenberg, P Smits, PV Hauschka The American journal of pathology 177 (3), 1459-1469, 2010 | 69 | 2010 |
| Molecular profiling of hepatocellular carcinoma using circulating cell-free DNA AO Kaseb, NS Sánchez, S Sen, RK Kelley, B Tan, AG Bocobo, KH Lim, ... Clinical Cancer Research 25 (20), 6107-6118, 2019 | 68 | 2019 |
| Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1) Y Naito, H Aburatani, T Amano, E Baba, T Furukawa, T Hayashida, ... International Journal of Clinical Oncology 26, 233-283, 2021 | 62 | 2021 |
| Single agent and synergistic activity of the “first-in-class” dual PI3K/BRD4 inhibitor SF1126 with sorafenib in hepatocellular carcinoma AR Singh, S Joshi, AM Burgoyne, JK Sicklick, S Ikeda, Y Kono, JR Garlich, ... Molecular cancer therapeutics 15 (11), 2553-2562, 2016 | 59 | 2016 |
| Endostatin lowers blood pressure via nitric oxide and prevents hypertension associated with VEGF inhibition SB Sunshine, SM Dallabrida, E Durand, NS Ismail, L Bazinet, AE Birsner, ... Proceedings of the National Academy of Sciences 109 (28), 11306-11311, 2012 | 55 | 2012 |
| Analysis of tissue and circulating tumor DNA by next-generation sequencing of hepatocellular carcinoma: implications for targeted therapeutics S Ikeda, JS Lim, R Kurzrock Molecular cancer therapeutics 17 (5), 1114-1122, 2018 | 52 | 2018 |
| Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity S Kato, R Okamura, Y Kumaki, S Ikeda, M Nikanjam, R Eskander, ... Oncoimmunology 9 (1), 1708065, 2020 | 50 | 2020 |
| MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis S Ikeda, M Schwaederle, M Mohindra, DL Fontes Jardim, R Kurzrock Journal of hematology & oncology 11, 1-10, 2018 | 44 | 2018 |
